ArticleMolecular diversity2023

In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J).

Konstantinos G KalamatianosPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.